Archive | 2019
Postoperative UFT-/Tegafur-based Chemotherapy Versus Postoperative Radiotherapy for Early-stage Non-small Cell Lung Cancer:A Systematic Review and Network Meta-analysis
Abstract
OR Non-Small-Cell Lung Carcinomas [Title/Abstract] OR Nonsmall Cell Lung Cancer [Title/Abstract] OR Non-Small-Cell Lung Carcinoma [Title/Abstract] OR Non Small Cell Lung Carcinoma [Title/Abstract] OR Carcinoma, Non-Small Cell Lung [Title/Abstract] OR Non-Small Cell Lung Cancer [Title/Abstract] OR “Carcinoma, NonSmall-Cell Lung” [Mesh] AND placebo [Title/Abstract]) OR “Controlled Clinical Trial” [Publication Type] OR “Randomized Controlled Trial” [Publication Type]. Additional new studies were identified by reading included studies and relevant reviews. All of the postoperative chemotherapy regime was UTF/Tegarfur-based. This systematic review and meta-analysis is reported in accordance with the Preferred Items for Systematic Reviews and Meta-analysis (PRISMA) Statement and was registered at International Prospective Register of Systematic Reviews (number CRD42018095979). Randomized control trials were included if they met following criteria: (1) postoperative chemotherapy vs surgery alone; (2) postoperative radiotherapy vs surgery alone; (3) early-stage non-small cell lung cancer; (4) providing estimates of overall survival.